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Introduction 
Surgical revascularisation using bypass grafts remains 
the treatment of choice in patients with critical limb 
ischaemia and technical refinements have had a 
disappointing influence on patency rates. The autolo- 
gous saphenous vein is considered the best arterial 
conduit since its use resulted in better long term 
patency rates than any other ~aft, but failure rates 
vary from 20-75% in 5 years. Intimal hyperplasia, 
which is the main cause of graft failure is a continuing 
problem. 
Graft surveillance for early detection of compro- 
mised grafts and reconstruction before they occlude 
has a major impact on improvement of both cumu- 
lative graft patency and limb salvage rates. 2-9 How- 
ever, a widely accepted protocol for graft surveillance 
has not been established. Colour flow Duplex imaging 
(CFDI) is the most common method of graft 
surveillance. 9-~2 
Background 
Approximately 10-15% of grafts fail within the first 
month after insertion (immediate or early failure) and 
this is most commonly due to a technical error or 
misjudgment of patient selection i.e. failing to correct 
13 14 a severe proximal or distal arterial esion. ' Techni- 
cal errors include poorly constructed suture line 
restricting the flow, intimal flaps, twisted graft, inap- 
propriate placement and tunneling, intraoperative 
overestimation of flow rate, branch ligature place- 
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ment, missed valve or an arteriovenous fi tula (with in 
situ vein grafts).~5 There exists a continuing failure rate 
over the next 12-18 months (intermediate failure) and 
a constant but low failure rate each year thereafter 
(late failure). 16-1s Intermediate failure is mainly due to 
stricture development within the vein graft and 
accounts for up to 80% of failures within 5 years after 
operation. 19-21 The strictures are the result of myointi- 
mal hyperplasia, the proliferative response of smooth 
muscle cells of the vessel wall that is triggered by 
trauma. 22-2s All types of conduits have been involved 
in the hyperplastic process but in the synthetic grafts 
the lesions are at the anastomoses, usually at the distal 
one. Synthetic grafts require higher flow rates to 
maintain patency because they lack true endothelium 
and therefore have a lower thrombotic threshold than 
autologous vein grafts. 19"26 Late failure (2-3% 
annually) is most commonly due to progression of 
atherosclerosis in the native vessels. Outflow (popli- 
teal or tibial-peroneal) atherosclerosis progresses com- 
monly faster than the inflow (aortoiliac) disease, 
leading to an increase of outflow resistance predispos- 
ing to graft thrombosis. Table 1 presents data with 
respect o location of strictures developed in the graft 
and related arteries. 
Why Surveillance? 
In the early years of these procedures, urgeons were 
disappointed to find occluded grafts in patients who 
had not developed symptoms or signs and had no 
warning reduction in ankle pressure. It is now known 
that intervening in a failing but still functioning raft 
before its occlusion greatly improves the patency rates 
4 20 26 34 35 and most importantl3~ preserves the limb . . . .  
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Table 1. Location of new lesion development within the graft and native arteries 
Author Graft characteristics Follow-up Surveillance methods Location of stenoses 
Veith 198427 191 compromised grafts 2 years ABI 40% inflow 
(av and PTFE) Arteriography 35% intragraft 
Grigg 198828 19/80 isv 12 (3-18) months 
Berkowitz 19893 109 /521 rsv 6 year period 
Taylor 199029 66/412 (73% av, 27% PTFE 22 (9-48) months 
(prospective) or composite) 
26% outflow 
ABI 35% proximal anastomosis 
IV DSA 55% body of the graft 
Duplex 10% distal anastomosis 
ABI 27% inflow 
PVR 56% intragraft: 
Arteriography 54% proximal anastomosis 
21% midgraft 
25% distal anastomosis 
17% outflow 
Duplex 20% proximal anastomosis 
IV DSA 47% graft 
33% distal anastomosis 
11% inflow 
18% outlow 
48% graft 
23% anastomoses 
Bandyk 199130 83/396 av 5 year period Duplex 
(prospective) Arteriography 
Sanchez 199132 115 PTFE, 161 av/2187 PTFE 44 (4-120) months ABI 
and av grafts PVR 
Arteriography 
Wyatt 199132 34/56 av 18 months ABI, Duplex 
(prospective) Impedance analysis 
IA DSA 
Donaldson 199233 85/455 isv 18.7 (1-82) months ABI 
Duplex 
Arteriography 
Mills 199322 38/227 rsv 22 (1-64) months Duplex 
(prospective) Angiography 
Idu 19939 58 / 187 av 21 (1-63) months CFDI 
IA DSA 
Mattos 19931° 62/170 av 39 month period ABI 
CFDI 
Angiography 
(not always) 
PTFE VEIN 
34% inflow 35% 
2% prox. anast. 4% 
5% midgraft 36% 
3% dist. anast. 5% 
56% outflow 20% 
21% proximal anastomosis 
26% body graft 
53% distal anastomosis 
4% inflow 
33% perianastomotic 
44% intragraft 
19% outflow 
16% inflow 
74% intragraft 
10% outflow 
14% inflow 
24% prox. anastomosis 
52% body of the graft 
7% distal anastomosis 
3% runoff 
3.6% inflow 
15.5% proximal anastomosis 
64.5% body of the graft 
11.8% distal anastomosis 
4.5% runoff 
Note that in the graft characteristics column the first number represents stenosed grafts and the second the grafts tudied. 
Follow up: Mean (range) CFDI: Colour Flow Duplex Imaging 
av: autologous vein grafts IA DSA: Intra-arterial Digital Subtraction Angiography. 
isv: in situ vein IV DSA: Intravenous Digital Subtraction Angiography. 
rsv: reversed saphenous vein ABI: Ankle/Brachial Index 
PVR: Pulse Volume Recordings 
(Table 2). Numerous  reports provide evidence that 
strictures impose a 3-6 fold risk of graft occlusion if 
left untreated s'21'44"45 (Table 3). Furthermore,  durable 
long-term improvement  of at least 10-19% in 3 year 
patency rates can be achieved by  developing a 
surveil lance program and selective secondary inter- 
vention; these results are comparable to the pr imary  
patency of undiseased bypasses. 3-5"9"36"49'5° A l though 
there is lack of double-bl ind prospective studies in the 
literature to demonstrate the superior ity of inter- 
vent ion in asymptomat ic  patients with strictured 
grafts, the existing evidence is in favour of inter- 
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Table 2. Patency rates after reconstruction of haemodynamicaUy compromised grafts 
Author Number of grafts Results/comments 
Sladen 198136 173 av 
Berkowitz 198137 134 av 
Brewster 198338 555 (63% av, 37% prosthetic) 
Bandyk 198539 69 isv 
Cohen 198634 322 av 
Berkowitz 198726 102 rsv 
Bandyk 19874 192 isv 
Grigg 198828 
Disselhoff 19894° 
Green 19904~ 
Buth 199142 
Bergamini 199143 
Donaldson 199233 
Mattos 1993 l° 
80 isv 
48 isv 
177 (54% isv, 28% rsv, 13% ePTFE, 5% HUV) 
116 av (78 isv, 38 ectopic) 
361 isv 
455 isv 
170 av (38% isv, 29% non rsv, 
17% rsv, 16% composite 
5 years secondary PR: 16% improvement after evision 
1 year primary PR: 67%; 1 year secondary PR: 86% 
2 years econdary PR: 79% (after PTA) 
5 years cumulative PR: 31% 
5 years limb salvage rate: 52% 
3 years primary PR for not diseased grafts: 86% 
3 years econdary PR for revised stenosed grafts: 81% 
5 years secondary PR: 82% 
5 years: primary PR: 47%; secondary PR: 70% 
5 years: Limb salvage rate: 86% 
FEM/POP: Primary mary PR: 48% 
Secondary PR: 89% 
FEM/TIM: Primary PR: 58% in 3 years 
Secondary PR: 80% 
i year primary PR: 79% 
I year secondary PR: 85% 
2 years primary PR: 63% 
2 years secondary PR: 79% 
Primary PR: I year 86%; 5 years 66% 
Secondary PR: i year 91%; 5 years 80%. 
2 years primary PR: 68% 
2 years secondary PR: 91% 
6 years primary PR 63% 
6 years econdary PR: 81% 
5 years cumulative primary PR: 70% 
5 years econdary PR: 79% 
i year CPR for not diseased grafts: 90%; 2 years: 83% 
i year CPR for diseased but revised grafts: 96%; 2 years: 88% 
PR: Patency Rates 
CPR: Cumulative Patency Rates 
PTA: Percutaneous Transluminal Angioplasty 
isv: in situ vein 
rsv: reversed saphenous vein 
non rsv: non reversed saphenous vein 
av: autologous vein 
HUV: Human Umbilical Vein 
vent ion 3'34'35'38'42 and intervention in occ luded grafts 
is an unsatisfactory opt ion (Table 4) with long term 
patency rates less than 40%. 6'34"52"55'57-59 
Therefore, identif ication of failing grafts prior to 
their occlusion seems logical and periodic surveil lance 
of infrainguinal grafts has become a common policy. 
Surveillance: Which Method? 
The ideal method  for surveil lance should be non- 
invasive, universal ly feasible and applicable, repro- 
ducible, simple, quick and easy to perform, inex- 
pensive, able to detect lesions and their progression 
within both the graft and the native vessels, and most 
importantly,  h ighly sensitive and specific. 
1. Clinical examination 
For many  years grafts were assessed by symptoms 
and examination, reserving ang iography for highly 
suspicious cases of deteriorating rafts. Clinical exam- 
ination relies on pulse palpation, deve lopment  of 
bruits, segmental  doppler  pressure measurements  and 
pulse vo lume recordings (PVR). Clinical examinat ion 
alone could not however  accurately detect compro-  
mised grafts that remained patent. 4"7'39'6°-62 Many  of 
the l imbs in these series never had palpable distal 
pulses despite a patent graft. In addition, palpat ion is 
63 1 notor iously unreliable. Pulses may be enhanced by  
reflected waves f rom a very high peripheral  resistance 
and normal  pulses may feel weak  in obese patients. 
Mozersky et al. in 1972 described the use of physio-  
logic tests (segmental eg pressures and standard 
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Table 3. Natural history of stenosed grafts 
Author Graft characteristics Follow-up Results 
Grigg 46 19/75 isv i year (3-18) month 
(prospective) 
Moody 47 22/80 av 13 months 
(prospective) 
Moody 5 14 / 63 av 11.2 months (9-21) 
(prospective) 
Taylor 29 66/412 (av, PTFE) 22 months (9-48) 
(prospective) 
Chang 7 47/350 isv 4 year period 
Buth 42 43/116 av 2 years 
Nielsen 48 15/66 av 3 months 
Idu 9 58/201 av 21 months (1-63) 
Mattos 1° 62/170 av 39 month period 
21% of grafts with stenosis <65% occluded 
26% of strictures in grafts with stenosis <65% became severe 
7% of not diseased grafts occluded 
22.7% of strictured grafts occluded 
6.9% of not stenosed grafts occluded 
65% of strictures remained stable 
0% occlusion in not diseased grafts 
12.5% of stenosed but revised grafts occluded 
12.5% of mildly stenosed (an untreated) grafts occluded 
23% of failing and revised grafts occluded 
0% of not diseased grafts occluded 
0% occlusions in asymptomatic patients with grafts having less than 50% stenosis 
19% of grafts with stenoses >50% occluded (treated or not) 
13% of stenosed but revised grafts occluded 
47% of not revised stenosed grafts occluded 
0% of grafts with <50% stenosis occluded 
6% occlusions in initially normal grafts 
28.5% occlusions in stenosed but revised grafts 
63% occlusions in uncorrected stenosed grafts 
% Ocdusions 
<50% DR 50-69% DR >70% DR Total 
40 Revised grafts 9 (1/11) 10 (3/29) 10% 
18 Non-revised 0 57 (4/7) 100 (3/3) 39% 
9% occlusions in 108 not stenosed grafts 
26% occlusions in 38 uncorrected stenosed grafts 
8% occlusions in 24 stenosed but revised grafts 
Note that in the graft characteristics column the first number represents stenosed grafts and the second the grafts tudied. 
Follow up: Mean (range); mo: months; yrs: years 
isv: in situ vein 
rsv: reversed saphenous vein 
av: autologous vein 
DR: Diameter Reduction 
treadmil l  walking) to fo l low-up patients. 16 Some 
patients with abnormal  tests had developed severe 
angiographic lesions wi thout  describing any change 
in symptoms and this was conf i rmed both pre- 
spectively and retrospectively. Twenty to fifty per cent 
had no symptoms despite significant graft stenosis 
(Table 5). Even the combinat ion of symptoms and 
clinical examinat ion was shown to be insensi- 
tive. 26'34"43 Thus, further tests were necessary. 
2. Ankle-brachial index 
Doppler  der ived ankle systolic pressures became the 
serial fo l low-up technique of choice in the 1970's since 
it is a simple, cheap, quick, reproducible test. 66 It was 
proposed that a decrease of 0.15 or more in the resting 
ankle-brachial index (ABI) was associated with failing 
grafts. 17'37 Nevertheless, this drop of ABI is close to the 
measurement  error, indicating that a large number  of 
false positives and false negatives cases might  
undergo an unnecessary angiogram. 67 A postoper-  
ative increase of less than 0.4 may be an indicator for 
68 early failure, and early resting ABI less than 0.85 as 
a predictor of late failure. 69 
Persistently low ABI is considered a sign of sig- 
nificant in- or outf low disease. The ABI has been 
extensively evaluated as a screening method and has 
been found to have a l imited value in identi fy ing graft 
stenosis (Table 6), especially in diabetic patients with 
stiffened and incompressible distal vessels and in in 
situ vein distal grafts with small calibre and low 
34465560 flow. ' ' ' ' Hyperaemia  us ing cuff occlusion for 2-3 
min or a standard treadmil l  exercise test (1 min walk, 
hor izontal ly or at 10%, at a speed of 3-4 k in /h )  72 may 
reveal some und iagnosed stenoses with resting ABI 
measurements  when there is a drop greater than 0.2, 
but this test has low sensitivity and it cannot be 
appl ied in all patients. 6° More recent studies report 
significant errors of ABI in detecting raft lesions, 50% 
of which may be missed. 9'n'12'71 
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Table 4. Outcome of graft revision (Thrombolysis, thrombectomy, PTA, Surgery) preceded by graft occlusion 
Author / graft ype Data 
Whittemore 198120 (109 failed av) 
Sladen 198136 (13 thrombosed rsv) 
McNamara 198651 (19 thrombosed PTFE) 
Cohen 198634 (29 failing av/25 failed av) 
Green 198652 (37 failing/75 thrombosed av 
and prosthetic) 
Ascer 198753 (165 PTFE) 
Graor 198854 
Belkin 199055 (22 failed av) 
Miller 199256 (23 failed av) 
Donaldson 199233 
5 years CPR: 80% for stenoses repaired prior to occlusion 
19% for stenoses repaired after thrombectomy 
5 years CLS: 50% after secondary econstructions 
I year: 23% PR of revised grafts after thrombectomy; 46% amputation rate 
2 years: 80% secondary PR of failing grafts 
6 months PR after thrombolysis: 25% 
5 years CPR: 82% for stenoses that repaired (patch angioplasty) prior to occlusion 
28% for stenoses that repaired after thrombectomy 
Better esults when a new graft is inserted instead of revision of a thrombosed one 
CPR for revision of a failing but patent graft: I year: 89%; 3 years: 77% 
CPR for revision of thrombosed grafts: I year: 33%; 3 years: 26% 
Better esults when a new graft is inserted instead of revision (PTA, angioplasty) of a 
thrombosed one after succesful thrombolysis 
2 years econdary PR: 83% for failing grafts 
2 years econdary PR: 23% for revised thrombosed grafts 
I year PR following successful thrombolysis and surgical revision: 20% 
I month PR after thrombolysis alone: 86% (n=22) 
I month PR after thrombectomy alone: 42% (n=38) 
LTP following successful thrombolysis and revision: 1 year: 37%; 3 years: 23% 
LSR following further intervention after secondary failure of revision that follows 
successful thrombolysis: I year: 67%; 3 years: 60% 
LTP following successful thrombolysis and subsequent procedures: 52% in I year 
(including 5new bypasses) 
2 years CPR: 95% for revised failing but patent grafts (n=22) 
2 years CPR: 22% for revised grafts after their thrombosis (n=40) 
PR: ParencyRate 
CPR: Cumulative Patency Rate 
LTP: Life Table Analysis of Patency 
CLS: Cumulative Limb Salvage 
LSR: Limb Salvage Rate 
rsv: reversed vein 
av: autologous vein 
Table 5. Prevalence of clinical signs ans symptoms in patients with 
severely stenosed grafts 
Berkowitz 198137 
Bandyk 198564 
Cohen 198634 
Wolfe 19876o 
Disselhoff 198940 
Moody 19905 
Holme 199265 
Idu 19939 
40% were asymptomatic, with normal distal 
pulses 
32% were asymptomatic 
24% were asymptomatic 
23% were asymptomatic 
62% were asymptomatic with normal pulses 
89% were asymptomatic with normal pulses 
61% were asymptomatic prior to occlusion 
67% were asymptomatic 
3. Duplex scanning 
Duplex  u l t rasonic  imag ing  us ing  a 7.5 or a 5.0 MHz  
transducer ,  became a power fu l  tool  in survei l lance 
prov id ing  both  an image of the graft  and  its haemody-  
namics.  A number  of measurements  combined  wi th  
Dopp ler  waveform analys is  of b lood  f low veloc i ty  
have been proposed  as accurate in ident i fy ing  steno- 
ses. 46 Dup lex  der ived  graft vo lume f low (GVF) is a 
rather  unsat is factory  ind icator  of stenosis as it is 
Table 6. Detection of stenosis by a decrease in Ankle-Brachial 
Index (ABI) greater than 0.15 
% Stenoses 
detected 
Author by ABI Comments 
Bercowitz 198137 91 
Cullen 19867o 80 Prospective.20% detected by toe 
pressure 
Wolfe 19876o 66 Prospective. Post exercise ABI was 
also used 
Bandyk 198864 64 30% of patients had incompressible 
tibials 
Disselhoff 19894o 31 Additional 15% detected by PVR 
Wyatt 199132 73 Post exercise ABI was also used 
Holme 199265 29 
Laborde 199211 48 
Wolve 199271 27 Prospective 
Idu 19939 38 
Davies 199412 51 Decrease in ABI>0.1 
poor ly  reproduc ib le  and  vu lnerab le  to cardiac output  
and  per iphera l  resistance changes. 73 In addi t ion,  f low 
measurements  re ly on deta i led  est imat ion Of lumina l  
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diameter (these vary in relation to the fourth power of 
the radius) so that a small inaccuracy in diameter 
measurement dramatically alters the flow. Peak sys- 
tolic velocity usually measured in the normal midgraft 
portion, has been proposed by Bandyk et al. as 
indicating a failing graft when it is less than 45 cm/s 
in either vein or PTFE grafts. Using this criterion, 96% 
of failing grafts were identified. 39 Although other 
studies 3°'41 supported the use of this criterion, we 
believe that it identifies only a minority of significant 
graft stenoses. 1°'42'74-76 However, PSV < 45 cm/s has 
been found to correlate well with a high incidence of 
occlusion during follow-up. 39 Other measurements 
used as indicators of a failing graft include a decrease 
in PSV greater than 30 cm/s from the previous test, a 
change in the graft flow waveform from a triphasic to 
a bi- or monophasic pattern, distal graft flow lower 
than 25 ml/min and a ratio of hyperaemic/resting 
distal bypass flow less than 2.5.7"4°'64These measure- 
ments have been advocated because velocities less 
than 45 cm/s may occur in normal large diameter 
grafts whereas veins with a small luminal calibre (e.g. 
less than 4 ram) rarely develop flow velocities lower 
than 45 cm/s even in the presence of a tight stenosis. 
Maximal systolic velocity greater than 110 cm/s 
throughout the graft, with monophasic waveform and 
severe spectral broadening has been proposed as a 
reasonable indicator of graft stenosis greater than 
42 77 50%, ' provided that the patient s blood pressure 
remains normal. Cullen et al.7°advocated that Doppler 
shifts greater than 6 kHz (170 cm/s) indicate stenoses 
greater than 50%. PSV greater than 150-180 cm/s 
when measured intraoperatively, has been proposed 
as an indication of angiography. 78Velocities higher 
than 300 cm/s indicate significant stenoses (greater 
than 70% in diameter reduction). 79 Maximal end- 
diastolic velocity greater than 20 cm/s has also been 
considered as a reliable predictor of severe stenosis, 
with the optimal measurement taken very close to the 
site of maximal diameter eduction. 42"79'8° 
For stenoses within the graft we have found the 
simple V2/V1 ratio to be the most reliable and rely 
entirely on this measurement alone. The V2/V1 ratio 
(V2: peak systolic velocity at the site of maximal 
stenosis, V1 within 2 cm upstream) has been shown to 
provide an accurate estimation of the degree of 
stenosis. 28 A Va/V1 > 2 characterises a tenosis greater 
than 50% in diameter reduction. 42"46 A V2/V1 >3 
indicates a severe stenosis, 7° and is an indication for 
urgent angiography. The advantage of a ratio is that 
changes of graft flow due to changes in peripheral 
resistance or cardiac output are annulled. This allows 
accurate measurement of the progression of stenosis 
between visits. The unreliable measurement of the 
diameter is unnecessary and it is the change in peak 
systolic velocity between two points that denotes 
stenosis, not the average velocity of the graft. 11"12'74'76 
Graft haemodynamics hange postoperatively with a 
fall in graft flow within 6 months. This is due to an 
increase in impedance by approximately 19% and 
decrease in compliance, while PSV falls by about 
29% 7,12,76 
The addition of a colour coding facility on a Duplex 
scanner has made the examination quick and simple. 
It provides a "railroad" for appropriate and quick 
positioning of the sample volume to record peak 
velocities in both the graft and the native arteries 
either proximally or distally. 74'81 Changes in velocity 
are indicated by alteration in colour-coded images that 
can be interrogated more carefully with doppler. It 
also improves imaging of difficult deep area. 42'76 
Colour-coded Duplex scanners although expensive, 
have simplifed the test. 
4. Impedance analysis 
Input impedance of the graft and run-oft vessels 
derived from non-invasive measurement of instanta- 
neous blood flow velocity and pressure has been 
proposed as an effective surveillance method. 32 Pulsa- 
tile pressure (pulse volume recordings) using segmen- 
tal air plethysmography cuffs and pulsatile flow 
recordings using a Doppler velocimeter are obtained. 
A computer assisted analysis of signals and Fourier 
waveform transformation is used to predict mean 
limb impedance values for the thigh and calf. For the 
concept of impedance in terms of the viscous resis- 
tance of a pulsatile system, fluid inertia and vessel 
compliance are important. A high level of impedance 
(thigh or calf score > 0.45) indicates a graft in jeopardy 
requiring angiography. A recent study demonstrated 
that the accuracy of impedance analysis in identifying 
grafts at risk was better than ABI and PSV but inferior 
to V2/V1 ratio. 12 However, this is a single centre 
experience and more studies are needed to establish 
its routine use for surveillance. 
5. Angiography 
Szilagyi et aI. drew our attention to graft stenosis 20 
years ago by performing routine postoperative 
angiography in a series of patients. 6 This policy could 
not be widely pursued until the advent of intravenous 
digital subtraction angiography (IVDSA) which made 
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Table 7. Time course of graft-threatening stenoses development 
Author Graft characteristics FU Surveillance method Time of stenosis development 
Berkowitz 198137(*) 30/134 av 3 months-8 years ABI 
Angiography 
Brewster 198338(*) 188/555 (av and prosthetic) 6 months-3 years PVR, ABI 
Segmental pressures 
Angiography 
Grigg 198828 19/80 isv 12 months (3-18) ABI, Duplex, IVDSA 
Moody 19905 14/63 av 11.2 months (9-21) Duplex 
(prospective) IVDSA 
Taylor 199029 66/412 (av and PTFE) 22 months (948) Duplex 
(prospective) 1VDSA 
Buth 199142 43/116 av 2 years CFDI 
IADSA or IVDSA 
Bell 199250 25/50 av 12 months ABI 
Duplex 
Angiography 
Donaldson 199233 85/455 isv 18.7 months (1-82) ABI, Duplex, Angiography 
Mills 199321 29/227 rsv 22 months (1-64) Duplex 
(prospective) Angiography 
Sanchez 19932 91/1420 PTFE 47 months (2-123) PVR, ABI 
Duplex 
Angiography 
Idu 19939 58/187 av 21 months (1--63) CFDI 
IADSA 
Mattos 1993 l° 62/170 av 39 month period ABI CFDI 
occasionally Angiography 
77% within the 1st year 
1-2% thereafter 
65% during the 1st year 
79% within the 2nd year 
89% within the first 6 months 
94% within the 1st 6 months 
6% between 6-12 months 
100% during the 1st year 
81% within the 1st year 
The rest between 12-36 month: 
32% in 4-6 weeks 
36% between 1.5-3 months 
12% between 3-6 months 
16% between 6-9 months 
4% between 9-12 months 
76% within the 1st year 
70% within 1st year 
80% within 1.5 years 
62% within 1st year 
71% within 18 months 
79% within 2 years 
21% within 3 months 
28% between 3-6 months 
36% between 6-12 months 
3% between 12-18 months 
12% after 18 months 
77% within the 1st year 
95% within the 2nd year 
Note that in the graft characteristics olumn the first number represents stenosed grafts and the second the grafts tudied. 
(*): Time course of graft failure has been estimated rather than stricture development 
FU: Mean follow up (range) CFDI: Colour Flow Duplex Imaging 
mo: months PVR: Pulse Volume Recordings 
yrs: years IA DSA: Intra-arterial Digital Subtraction Angiography 
isv: in situ vein IV DSA: Intravenous Digital Subtraction Angiography 
rsv: reversed saphenous vein ABh Ankle/Brachial Index 
av: autologous vein PVR: Pulse Volume Recordings 
ang iograph ic  fo l low-up of asymptomat ic  pat ients  
possible.  29'46 This remains  an accurate method but  is 
expens ive  and  pat ients  dis l ike the repeated  test, so 
that compl iance can be a prob lem.  We nevertheless  
cons ider  intrarter ia l  DSA mandatory  before t reat ing a 
stenosis that  has been ident i f ied on Dup lex  
survei l lance.  
6. Magnet resonance angiography 
Magnet ic  resonance ang iography  remains  in the ear ly  
stages of deve lopment ,  but  a recent s tudy  ident i f ied 
75% of ang iograph ica l ly  fai l ing or fa i led grafts w i th  a 
tendency  for overd iagnos is  ( turbulence is ident i f ied as 
a stenosis), s2 Interpretat ion errors may lessen in the 
future and  thus reduce the need for convent iona l  
angiography.  
Surveillance : How Often? For How Long? 
Survei l lance programs are costly, t ime consuming  and  
require appropr ia te  technical  support .  Fur thermore ,  
they  must  fo l low careful  in t raoperat ive  moni tor -  
ing. 4'39"76'83 If the graft is exposed  Dopp ler  is p robab ly  
as effective as Dup lex  and  is cheaper  and  less 
cumbersome.  Many  stil l re ly on angiography.  Ear ly  
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failure can thus be minimised. 78 The vast majority of 
lesions develop within the first 12 months and may be 
significant within 5 weeks (Table 7). Most surveillance 
programs therefore suggest that the first test 
(primarily Duplex scanning) is performed at 6 weeks 
and then on the 3rd, 6th, 9th and 12th 
month .  2'12'29'34'40'50'79'84 Many centres then suggest a 
further 6 monthly assessment but in our experience 
the number of grafts salvaged at this stage does not 
justify the cost. 8'28'29 Grafts will continue to fail but at 
an annual rate of approximately 2-3% and this does 
not justify the cost involved with continuing surveil- 
lance of all grafts. 29"31"41 Other authors favour surveil- 
lance for at least 2 years. 2"85 CertainlN controlled 
randomised studies are required before any definite 
answer is given on the time aspect of surveillance. 
Some individual grafts are at greater failure risk (Table 
8). Mills et al. have proposed that a less intense 
surveillance course may be required in a low risk 
group of grafts, especially for those with normal initial 
findings. 92'93 His careful study suggests that a vein 
graft with no blemishes is unlikely to develop sig- 
nificant stenosis. However, those with areas of thick- 
ening, turbulence or vein to vein anastomoses are at 
risk. The first randomised study 94 on the effect of 
surveillance showed that under intensive surveillance 
with Duplex scanning the grafts had better primary 
and secondary patency rates than those in the routine 
follow-up examination (primary 78% vs. 56%, secon- 
dary 82% vs. 56%, p < 0.05). No difference was seen in 
patients with PTFE and composite grafts. 
Table 8. Grafts at higher isk for failurre 
1. Intrinsic vein disease. 
Histology: Sclerotic, thickwalled and calcified veins with 
hypercellular intima, lympholytic (with T-cells preponderance) 
and macrophage infiltrates. 86,87 
Elastic properties; Low compliance (ie. <0.13%/mmHg). 84,88 
2. Infragenicular not autologous grafting. 
3. The indication for the operation was critical limb 
ischaemia.19,38, 89 
4. Poor run-off arterial tree (even in situ vien conduits) or bypass to 
an isolated popliteal segmertt. 61,90 
5. Diabetic patient. 86 
6. Early stenosis development. 42 
7. Limitred experience ofthe surgical team. 43 
8. Revised graft after successful thrombolysis or thrombectomy 
[Table 4]. 
9. Vein grafts requiring modification before insertion. 43 
10. Aortoiliac disease, irrespective if treated or not with PTA or 
atherectomy. 91 
Is Graft-surveillance Cost Effective? 
The implications and preferences for surveillance 
methods may be biased by individual skills and 
expertise but we are increasingly called to justify our 
management by health economists. We have sug- 
gested that limb loss has to be prevented in only 2% of 
patients for a Duplex scanning surveillance program 
including six examinations in a year to be cost 
effective. 8 The reduction in the examination time on 
colour duplex scanners permits more tests to be 
performed and that may well add financial benefits. 
Surveillance policies beyond the first postoperative 
year have not yet been justified with respect o their 
cost effectiveness. If we are able to confidently identify 
high risk grafts then targeted surveillance would be 
even more worthwhile. 
Where Do We Go From Here? 
Arterial reconstructions a "limb salvage" procedures 
are widely used. However, the impact of these 
procedures on amputation rates has been difficult to 
assess ince the incidence of peripheral arterial disease 
clearly increases in an ageing population, 95 making 
more individuals prone to leg ischaemia. Recent 
studies have addressed this problem in terms of 
reducing amputation rate and improved quality of life 
with reconstruction, but the case is not convincingly 
proven. 96 Although a 9-22% decline in amputation 
rates has been reported, 35"97-99 other studies failed to 
support these observations. ~°°-~°3 Ironically, some 
studies have claimed that the extensive use of arterial 
reconstruction was associated with an increase in 
amputations. 1°°'1°L1°3"1°4 Does this discrepancy repre- 
sent any differences on various risk factors trends, on 
decision making and overdiagnosis, or on patients' 
management and changing treatment policies during 
time? These judgmental issues must continue to be 
addressed but once distal reconstruction has been 
undertaken every attempt must be made to ensure 
success. At present, the intraoperative t chniques that 
have been introduced seem to improve out- 
come. 13'1°5-1°7 Better modification of risk factors, 
refinement of conduits, improvement of our knowl- 
edge on blood coagulation and on intimal proliferative 
process, may all have a positive influence in the 
future. But for the time being, detailed vein graft 
surveillance is a powerful tool in detecting vein graft 
stenosis - -  the cause of nearly 80% of graft failures. 
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